Rerouted bile acid thwarts tumor spread in colorectal cancer mouse model

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has found that bile acid diversion in Roux-en-Y gastric bypass (RYGB) reduces colorectal tumor growth and metastasis independent of weight loss, potentially reshaping future cancer treatment approaches.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup